Compare SRTA & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRTA | CLPT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 530.4M | 467.9M |
| IPO Year | 2019 | 2009 |
| Metric | SRTA | CLPT |
|---|---|---|
| Price | $5.43 | $15.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $7.81 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 680.8K | 532.8K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 242.86 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $197,141,000.00 | $36,971,000.00 |
| Revenue This Year | $39.27 | $45.67 |
| Revenue Next Year | $8.52 | $19.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $3.95 | $8.27 |
| 52 Week High | $6.50 | $30.10 |
| Indicator | SRTA | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 47.81 |
| Support Level | $5.35 | $13.21 |
| Resistance Level | $5.48 | $15.29 |
| Average True Range (ATR) | 0.18 | 0.57 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 58.89 | 38.80 |
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.